{"filing":{"accession_number":"0001193125-26-386091","cik":"0001156375","ticker":"CME","company_name":"CME GROUP INC.","form":"8-K","filing_date":"2026-09-09","report_date":"2026-09-09","primary_document":"d157844d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1156375/000119312526386091/d157844d8k.htm"},"events":[{"id":32289,"run_id":29666,"accession_number":"0001193125-26-386091","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"CME Group announced multiple senior executive appointments: Jack Tobin to Deputy CFO (November 2026) and then CFO (March 2027), Matthew Render to Chief Accounting Officer (November 2026), and John Marchese to General Counsel (September 2026). These are material C-suite appointments affecting the company's financial and legal leadership structure. While Tobin's appointment involves a transition from his prior role as Chief Accounting Officer, the principal disclosed action is his promotion to CFO and joining the Management Team, making this an appointment event.","company_name":"CME GROUP INC.","ticker":"CME","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":[{"id":35434,"accession_number":"0001193125-26-386091","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"CME Group announced multiple senior executive appointments: Jack Tobin to Deputy CFO (November 2026) and then CFO (March 2027), Matthew Render to Chief Accounting Officer (November 2026), and John Marchese to General Counsel (September 2026). These are material C-suite appointments affecting the company's financial and legal leadership structure. While Tobin's appointment involves a transition from his prior role as Chief Accounting Officer, the principal disclosed action is his promotion to CFO and joining the Management Team, making this an appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T15:16:38.943124+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35434,"accession_number":"0001193125-26-386091","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"CME Group announced multiple senior executive appointments: Jack Tobin to Deputy CFO (November 2026) and then CFO (March 2027), Matthew Render to Chief Accounting Officer (November 2026), and John Marchese to General Counsel (September 2026). These are material C-suite appointments affecting the company's financial and legal leadership structure. While Tobin's appointment involves a transition from his prior role as Chief Accounting Officer, the principal disclosed action is his promotion to CFO and joining the Management Team, making this an appointment event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T15:16:38.943124+00:00","company_name":"CME GROUP INC.","ticker":"CME","filing_date":"2026-09-09"}]}